The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
Open accessAbstract
Purpose: We tested the hypothesis that baseline plasma levels of C-reactive protein (CRP) are associated with risk of incident cancer in the general population and early death in patients with cancer. Patients and Methods: A total of 10,408 individuals from the Danish general population who had CRP measured at baseline were observed for up to 16 years; 1,624 developed cancer, and of these, 998 patients died during follow-up. Follow-up was 100% complete. We excluded individuals with a cancer diagnosis at baseline. Results: Baseline CRP levels more than 3 versus less than 1 mg/L were associated with multifactorially adjusted hazard ratios of 1.3 (95% CI, 1.0 to 1.6) for cancer of any type, 2.2 (95% CI, 1.0 to 4.6) for lung cancer, 1.9 (95% CI, 0.8 to 4.6) for colorectal cancer, and 0.7 (95% CI, 0.4 to 1.4) for breast cancer. Corresponding hazard ratios for the highest versus the lowest quintile of baseline CRP levels were 1.3 (95% CI, 1.0 to 1.6), 2.1 (95% CI, 1.2 to 3.8), 1.7 (95% CI, 0.8 to 3.2), and 0.9 (95% CI, 0.5 to 1.7), respectively. Multifactorially adjusted hazard ratios for early death in patients with cancer were 1.8 (95% CI, 1.2 to 2.7) for CRP more than 3 versus less than 1 mg/L and 1.4 (95% CI, 1.1 to 1.7) for the highest versus the lowest quintile. Elevated CRP levels were associated with early death in patients with cancer having localized disease, but not in those with metastases (interaction; P = .03). Conclusion: Elevated levels of CRP in cancer-free individuals are associated with increased risk of cancer of any type, of lung cancer, and possibly of colorectal cancer. Moreover, elevated levels of baseline CRP associate with early death after a diagnosis of any cancer, particularly in patients without metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics
Burtis, E. B. C. A., Ashwood, E. R., & Bruns, D. E. (2011) · Medical Entomology and Zoology · Cited by 2,190
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationClarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
The Danish Cancer Registry--history, content, quality and use.
Storm, H. H., Michelsen, E. V., Clemmensen, I. H., & Pihl, J. (1997) · PubMed · Cited by 790
C-Reactive Protein and the Risk of Incident Colorectal Cancer
Erlinger, T. P. (2004) · JAMA · doi:10.1001/jama.291.5.585 · Cited by 533
Il'yasova, D., Colbert, L. H., Harris, T. B., Newman, A. B., Bauer, D. C., Satterfield, S., & Kritchevsky, S. B. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0316 · Cited by 479
Heikkilä, K., Ebrahim, S., & Lawlor, D. A. (2007) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2006.051292 · Cited by 429
Siemes, C., Visser, L. E., Coebergh, J.-W. W., Splinter, T. A. W., Witteman, J. C. M., Uitterlinden, A. G., Hofman, A., Pols, H. A. P., & Stricker, B. H. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1381 · Cited by 354
Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancer
Ramsey, S., Lamb, G. W. A., Aitchison, M., Graham, J., & McMillan, D. C. (2007) · Cancer · doi:10.1002/cncr.22400 · Cited by 334
Scott, H. R., McMillan, D. C., Forrest, L. M., Brown, D. J. F., McArdle, C. S., & Milroy, R. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600466 · Cited by 322
Inflammation in the development of lung cancer: epidemiological evidence
Engels, E. A. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.4.605 · Cited by 299
Heikkilä, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J., Ben-Shlomo, Y., Ebrahim, S., & Lawlor, D. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-008-9212-z · Cited by 290
McMillan, D. C., Elahi, M. M., Sattar, N., Angerson, W. J., Johnstone, J., & McArdle, C. S. (2001) · Nutrition and Cancer · doi:10.1080/01635581.2001.9680613 · Cited by 250
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
Murri, A. M. A., Bartlett, J. M. S., Canney, P. A., Doughty, J. C., Wilson, C., & McMillan, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602922 · Cited by 211
A Prospective Study of Serum C-Reactive Protein and Colorectal Cancer Risk in Men
Gunter, M. J., Stolzenberg-Solomon, R., Cross, A. J., Leitzmann, M. F., Weinstein, S., Wood, R. J., Virtamo, J., Taylor, P. R., Albanes, D., & Sinha, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3631 · Cited by 205
C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies
Tsilidis, K. K., Branchini, C., Guallar, E., Helzlsouer, K. J., Erlinger, T. P., & Platz, E. A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23606 · Cited by 204
Schnohr, P. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2842 · Cited by 195
Plasma C-Reactive Protein and Risk of Cancer: A Prospective Study from Greece
Trichopoulos, D., Psaltopoulou, T., Orfanos, P., Trichopoulou, A., & Boffetta, P. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0626 · Cited by 176
Completeness of Cancer Registration in Denmark 1943–1966 and Efficacy of Record Linkage Procedures
Storm, H. H. (1988) · International Journal of Epidemiology · doi:10.1093/ije/17.1.44 · Cited by 142
C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in Women
Zhang, S. M., Buring, J. E., Lee, I.-M. M., Cook, N. R., & Ridker, P. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00008 · Cited by 123
Otani, T., Iwasaki, M., Sasazuki, S., Inoue, M., & Tsugane, S. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0708 · Cited by 119
The RANX05 Colorectal Cancer Study Group, Nielsen, H. J., Christensen, I. J., Sørensen, S., Moesgaard, F., & Brünner, N. (2000) · Annals of Surgical Oncology · doi:10.1007/bf02725342 · Cited by 115
Storm, H. H. (1991) · PubMed · Cited by 106
C-Reactive Protein and Risk of Breast Cancer
Zhang, S. M., Lin, J., Cook, N. R., Lee, I.-M. M., Manson, J. E., Buring, J. E., & Ridker, P. M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk202 · Cited by 99
Is C-Reactive Protein Specific for Vascular Disease in Women?
Rifai, N., Buring, J. E., Lee, I.-M. M., Manson, J. E., & Ridker, P. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00010 · Cited by 82
Colorectal Cancer and Serum C-reactive Protein Levels: a Case-control Study Nested in the JACC Study
Ito, Y., Suzuki, K. A. O., Tamakoshi, K., Wakai, K., Kojima, M., Ozasa, K., Watanabe, Y., Kawado, M., Hashimoto, S., Suzuki, S., et al. (2005) · Journal of Epidemiology · doi:10.2188/jea.15.s185 · Cited by 63
Heikkilä, K., Ebrahim, S. B. J., Rumley, A., Lowe, G. D. O., & Lawlor, D. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0093 · Cited by 56
Suzuki, K. A. O., Ito, Y., Wakai, K., Kawado, M., Hashimoto, S., Seki, N., Ando, M., Nishino, Y., Kondo, T., Watanabe, Y., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0005 · Cited by 52
Cited by
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32247-x · Cited by 1,344
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Iyengar, N. M., Gucalp, A., Dannenberg, A. J., & Hudis, C. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.4283 · Cited by 1,004
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
Allin, K. H., & Nordestgaard, B. G. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.599831 · Cited by 553
Self-citationStudy, A. C., Bojesen, S. E., Study, A. O. C., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), (GENICA), G. E. I. A. B. C., (SWE-BRCA), S. B. C. S., The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), (EMBRACE), E. S. O. B. &. B. M. C., (GEMO), G. M. O. C. R. I. B. M. C., Pooley, K. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2566 · Cited by 528
Self-citation
Metadata
- Authors
- Allin, K. H., Bojesen, S. E., & Nordestgaard, B. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-05-01
- Volume
- 27
- Issue
- 13
- Pages
- 2217-2224
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2131553129
- Cited by
- 419
- References
- 32
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.